ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $246,000 | -97.5% | 20,000 | +29311.8% | 0.11% | -69.0% |
| Q3 2016 | $10,000,000 | +27677.8% | 68 | -99.3% | 0.34% | +1625.0% |
| Q2 2016 | $36,000 | +20.0% | 10,000 | 0.0% | 0.02% | +17.6% |
| Q1 2016 | $30,000 | -28.6% | 10,000 | 0.0% | 0.02% | -19.0% |
| Q4 2015 | $42,000 | -8.7% | 10,000 | 0.0% | 0.02% | -22.2% |
| Q3 2015 | $46,000 | -37.8% | 10,000 | 0.0% | 0.03% | -42.6% |
| Q2 2015 | $74,000 | 0.0% | 10,000 | 0.0% | 0.05% | 0.0% |
| Q1 2015 | $74,000 | -22.1% | 10,000 | -50.0% | 0.05% | -39.0% |
| Q4 2014 | $95,000 | +33.8% | 20,000 | 0.0% | 0.08% | +37.5% |
| Q3 2014 | $71,000 | -24.5% | 20,000 | -2.6% | 0.06% | -24.3% |
| Q2 2014 | $94,000 | 0.0% | 20,540 | +2.7% | 0.07% | -2.6% |
| Q1 2014 | $94,000 | -6.0% | 20,000 | 0.0% | 0.08% | -5.0% |
| Q4 2013 | $100,000 | -19.4% | 20,000 | 0.0% | 0.08% | -25.9% |
| Q3 2013 | $124,000 | +36.3% | 20,000 | 0.0% | 0.11% | +35.0% |
| Q2 2013 | $91,000 | – | 20,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |